NasdaqCM - Nasdaq Real Time Price USD

IM Cannabis Corp. (IMCC)

1.4200

-0.1100

(-7.19%)

At close: April 25 at 4:00:00 PM EDT

1.5100

+0.09

+(6.34%)

After hours: April 25 at 7:54:03 PM EDT

IM Cannabis Provides Corporate Updates

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced the following corporate updates.

PR Newswire 15 days ago

IMCC
-7.19%
IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results

IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce its financial results for the fourth quarter and year ended December 31, 2024. Unless otherwise stated, all amounts are reported in Canadian dollars and are compared to the quarter ended December 31, 2023.

PR Newswire 26 days ago

IMCC
-7.19%
IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quarter and full year 2024 ended December 31, 2024, on Monday, March 31, 2025 before the market opens.

CNW Group last month

IMCC
-7.19%
IM Cannabis Announces Change of Auditors

IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, announces that it has changed its auditor from Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global (the "Predecessor Auditor") to Fahn Kanne & Co. Grant Thornton Israel (the "Successor Auditor") effective January 16, 2025. The Predecessor Auditor resigned effective January 16, 2025, at the Company's request, and the Company's board of directo

PR Newswire 3 months ago

IMCC
-7.19%
IM Cannabis Reports Third Quarter Financial Results

IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the third quarter ended September 30, 2024. All amounts are reported in Canadian dollars and compared to the quarter ended September 30, 2023, unless otherwise stated.

CNW Group 5 months ago

IMCC
-7.19%
IM Cannabis Closes Non-Brokered Private Placement led by Management and Concurrent Debt Settlement

IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further to its press release dated October 4, 2024 (the "October 4 Release"), the Company has closed its previously announced non-brokered private placement offering (the "Offering") effective today (the "Closing Date") through the issuance of 742,517 Units for gross proceed of C$2,138,448.96. Capitalized terms not o

CNW Group 5 months ago

IMCC
-7.19%
IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third 2024 ended September 30, 2024, on November 14, 2024, before the market opens.

CNW Group 5 months ago

IMCC
-7.19%
IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management

IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that it intends to undertake a non-brokered private placement offering of up to US$1,613,000 through the sale of approximately 625,000 units (each, an "Unit") at a price per Unit (the "Offering Price") calculated on the basis of the deemed price per common shares in the capital of the Company (each, a "Share") equal to the

PR Newswire 6 months ago

IMCC
-7.19%
IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that the preliminary sales results in Germany by its German subsidiary, Adjupharm GmbH ("IMC Germany"), for the third quarter of 2024 have significantly exceeded expectations, showing a remarkable 50% increase in revenue compared to the second quarter, where IMC Germany sold about CAD$ 3.5M. This outstanding growth

PR Newswire 6 months ago

IMCC
-7.19%
IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors

IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Shmulik Arbel has been appointed to the Company's board of directors (the "Board") effective September 9, 2024. Mr. Arbel brings a wealth of experience in strategic plans that drive profitability, as well as, finance and corporate governance, further strengthening the company's commitment to driving growth while focusing

CNW Group 7 months ago

IMCC
-7.19%
IM Cannabis Reports Second Quarter Financial Results

IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the second quarter ended June 30, 2024. All amounts are reported in Canadian dollars and compared to the quarter ended June 30, 2023, unless otherwise stated.

PR Newswire 8 months ago

IMCC
-7.19%
IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter 2024 ended June 30, 2024, on Wednesday, August 14, 2024, before the market opens.

PR Newswire 8 months ago

IMCC
-7.19%
IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced that on July 26, 2024, it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules (the "Minimum Bid Price Requirement"). IMC is now in compliance with all applicab

CNW Group 8 months ago

IMCC
-7.19%
IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further to its press release dated July 5, 2024, effective today the Company's common shares ("Common Shares") are trading on the Canadian Securities Exchange (the "CSE") and Nasdaq Stock Market LLC ("NASDAQ") on a 6:1 post-consolidated basis (the "Consolidation").

CNW Group 9 months ago

IMCC
-7.19%
IM Cannabis Announces Intention to Complete Consolidation

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company (the "Board") has approved a consolidation of its issued and outstanding common shares ("Common Shares") on the basis of one post-consolidated Common Share for every six pre-consolidated Common Shares (the "Consolidation").

PR Newswire 9 months ago

IMCC
-7.19%
IMCC Addresses Accelerated Growth in Germany Through new Supply Agreement with EU-GMP Certified Glasshouse Botanics and Announces a Change to its Board of Directors

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is experiencing accelerated growth in Germany after the April 1st partial legalization, further to the Company's press release dated March 25, 2024. Adjupharm GmbH's, IMC's German subsidiary ("Adjupharm" or "IMC Germany"), is supporting its growth by further bolstering its supply chain with an additional EU-GMP supplier, GlassHouse Botani

CNW Group 10 months ago

IMCC
-7.19%
IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that in order to preserve its cash for to support accelerated growth in Germany it has closed a non-brokered private placement (the "Offering") of secured convertible debentures of the Company (each, a "Debenture") for aggregate proceeds of $2,091,977. The Debentures are being issued to holders of short-term loans

CNW Group 10 months ago

IMCC
-7.19%
IMC announces the termination of a preliminary term sheet with Kadimastem Ltd., a public company traded on the Tel Aviv Stock Exchange to fully focus on the recently legalized German market

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announces the termination of the preliminary term sheet signed on February 13, 2024 with Kadimastem Ltd a public company traded on the Tel Aviv Stock Exchange under the symbol (TASE:KDST) ("Kadimastem").

CNW Group 10 months ago

IMCC
-7.19%
KMSTF
IM Cannabis Reports First Quarter Financial Results

IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the first quarter ended March 31, 2024. All amounts are reported in Canadian dollars and compared to the quarter ended March 31, 2023, unless otherwise stated.

CNW Group 11 months ago

IMCC
-7.19%
IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2024 ended March 31, 2024, on Wednesday, May 8, 2024, before the market opens.

PR Newswire 11 months ago

IMCC
-7.19%

Performance Overview

Return	IMCC	S&P/TSX Composite index (^GSPTSE)
YTD	-38.77%	+0.37%
1-Year	-58.26%	+12.91%
3-Year	-98.21%	+17.60%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

IM Cannabis Corp. (IMCC)

IM Cannabis Provides Corporate Updates

IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results

IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET

IM Cannabis Announces Change of Auditors

IM Cannabis Reports Third Quarter Financial Results

IM Cannabis Closes Non-Brokered Private Placement led by Management and Concurrent Debt Settlement

IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET

IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management

IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2

IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors

IM Cannabis Reports Second Quarter Financial Results

IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET

IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement

IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis

IM Cannabis Announces Intention to Complete Consolidation

IMCC Addresses Accelerated Growth in Germany Through new Supply Agreement with EU-GMP Certified Glasshouse Botanics and Announces a Change to its Board of Directors

IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany

IMC announces the termination of a preliminary term sheet with Kadimastem Ltd., a public company traded on the Tel Aviv Stock Exchange to fully focus on the recently legalized German market

IM Cannabis Reports First Quarter Financial Results

IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET

Performance Overview